Laboratory of Microbiology, The Rockefeller University, New York, NY 10065, USA.
Microb Drug Resist. 2013 Jun;19(3):153-9. doi: 10.1089/mdr.2013.0053. Epub 2013 May 9.
The overwhelming majority of methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates exhibit a peculiar heterogeneous resistance to β-lactam antibiotics: in cultures of such strains, the majority of cells display only a low level of methicillin resistance--often close to the MIC breakpoint of susceptible strains. Yet, in the same cultures, subpopulations of bacteria exhibiting very high levels of resistance are also present with variable frequencies, which are characteristic of the particular MRSA lineage. The mechanism of heterogeneous resistance is not understood. We describe here an experimental system for exploring the mechanism of heterogeneous resistance. Copies of the resistance gene mecA cloned into a temperature-sensitive plasmid were introduced into the fully sequenced methicillin-susceptible clinical isolate S. aureus strain 476. Transductants of strain 476 expressed methicillin resistance in a heterogeneous fashion: the great majority of cells showed only low MIC (0.75 μg/ml) for the antibiotic, but a minority population of highly resistant bacteria (MIC >300 μg/ml) was also present with a frequency of ∼10(-4). The genetic backgrounds of the majority and minority cells were compared by whole-genome sequencing: the only differences detectable were two point mutations in relA of the highly resistant minority population of bacteria. The relA gene codes for the synthesis of (p)ppGpp, an effector of the stringent stress response. Titration of (p)ppGpp showed increased amounts of this effector in the highly resistant cells. Involvement of (p)ppGpp synthesis genes may explain some of the perplexing aspects of β-lactam resistance in MRSA, since many environmental and genetic changes can modulate cellular levels of (p)ppGpp.
绝大多数耐甲氧西林金黄色葡萄球菌 (MRSA) 临床分离株对β-内酰胺类抗生素表现出特殊的异质性耐药:在这些菌株的培养物中,大多数细胞仅表现出低水平的甲氧西林耐药性——通常接近敏感株的 MIC 折点。然而,在相同的培养物中,也存在具有不同频率的表现出非常高水平耐药性的细菌亚群,这是特定的 MRSA 谱系的特征。异质性耐药的机制尚不清楚。我们在这里描述了一个用于探索异质性耐药机制的实验系统。将抗性基因 mecA 的拷贝克隆到温度敏感质粒中,引入完全测序的甲氧西林敏感临床分离株金黄色葡萄球菌 476 中。476 株的转导子以异质性方式表达甲氧西林耐药性:绝大多数细胞仅对该抗生素表现出低 MIC(0.75 μg/ml),但也存在少数高度耐药细菌(MIC >300 μg/ml),其频率约为 10(-4)。通过全基因组测序比较了大多数和少数细胞的遗传背景:唯一可检测到的差异是高度耐药细菌少数群体中 relA 的两个点突变。relA 基因编码 (p)ppGpp 的合成,这是严格应激反应的效应物。(p)ppGpp 的滴定显示,高度耐药细胞中这种效应物的含量增加。(p)ppGpp 合成基因的参与可能解释了 MRSA 中β-内酰胺耐药的一些令人费解的方面,因为许多环境和遗传变化可以调节细胞内 (p)ppGpp 的水平。